trending Market Intelligence /marketintelligence/en/news-insights/trending/VqB_Vuh7Xl6XDN7bkaCPRw2 content esgSubNav
In This List

Iovance Biotherapeutics names CFO

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Iovance Biotherapeutics names CFO

Iovance Biotherapeutics Inc. appointed Timothy Morris to be CFO, effective Aug. 14.

Morris most recently served as CFO and head of business development of AcelRx Pharmaceuticals Inc.